Haemonetics (HAE) Nexsys Upgrade Cycle Supports EPS to $185 PT Raised at Jefferies
Tweet Send to a Friend
Jefferies analyst Anthony Petrone raised the price target on Haemonetics (NYSE: HAE) to $185.00 (from $170.00) on the belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
